| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 12.7 -0.22 (-1.7%) | 05-29 11:06 | ||
| Open: | 12.82 | Pre. Close: | 12.92 |
| High: | 12.99 | Low: | 12.652 |
| Volume: | 2,259,276 | Market Cap: | 13373M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 13.246 - 13.297 | 13.297 - 13.348 |
| Low: | 12.706 - 12.767 | 12.767 - 12.828 |
| Close: | 12.823 - 12.915 | 12.915 - 13.007 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 15.45 One year: 18.05 |
| Support: | Support1: 11.06 Support2: 9.72 |
| Resistance: | Resistance1: 13.23 Resistance2: 15.45 |
| Pivot: | 11.88  |
| Moving Averages: | MA(5): 12.59 MA(20): 11.51 MA(100): 10.47 MA(250): 9.21 |
| MACD: | MACD(12,26): 0.67 Signal(12,26,9): 0.56 |
| %K %D: | %K(14,3): 92.54 %D(3): 93.22 |
| RSI: | RSI(14): 70.76 |
| 52-Week: | High: 13.76 Low: 6.07 Change(%): 44.4 |
| Average Vol(K): | 3-Month: 1732104 10-Days: 1023334 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.TEVA has closed below upper band by 11.7%. Bollinger Bands are 17.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty Generic | |
| Shares Out. (M) | 1100.00 |
| Shares Float (M) | 1090.00 |
| % Held by Insiders | 0.60 |
| % Held by Institutions | 54.67 |
| Shares Short (K) | 15880 |
| Shares Short Prior Month (K) | 26180 |
| Stock Financials | |
|---|---|
| EPS | -0.760 |
| Book Value (p.s.) | 12.350 |
| Profit Margin | -4.83 |
| Operating Margin | 17.61 |
| Return on Assets (ttm) | 3.3 |
| Return on Equity (ttm) | -5.8 |
| Qtrly Rev. Growth | 5.0 |
| Gross Profit (p.s.) | 6.855 |
| Sales Per Share | 15.545 |
| EBITDA (p.s.) | 4.264 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 941.00 |
| Levered Free Cash Flow (M) | 2540.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | -16.91 |
| PEG Ratio | 0.96 |
| Price to Book value | 1.04 |
| Price to Sales | 0.83 |
| Price to Cash Flow | 15.02 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
